Lung Cancer
Conditions
Keywords
Questionaires
Brief summary
The purpose of this study is to determine if collecting information and blood from a group of people who never smoked but who have lung cancer, is possible across the US. The investigators will collect information on each patient's diagnosis and treatments. If the collection is successful, blood samples will be used to try to identify new genes (which are the basic elements of heredity, passed from parents to their offspring), which may explain and predict why certain patients develop lung cancer without having smoked tobacco.
Interventions
After giving informed consent, all patients will be asked to complete questionnaire and will be asked to provide a blood sample for DNA analysis. The questionnaire will consist of a detailed smoking questionnaire, based on the most recent Centers for Disease Control and Prevention (CDC) Behavioral Risk Factor Surveillance System Survey Questionnaire.
Sponsors
Memorial Sloan Kettering Cancer Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 years or older * histologically and/or cytologically proven diagnosis of non-small cell lung cancer * never smoker, defined as having smoked less than 100 cigarettes over one's life-time * completed survey and inclusion form * signed informed consent
Exclusion criteria
* previous history of cancer (other than lung cancer) * living outside the United States * patients who cannot read English (as website and questionnaires will only be written in English) * unable to understand the protocol or to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the feasibility of an internet-based protocol to collect clinical information and biological specimens from 2,000 never smokers with lung cancer. | conclusion of the study |
Countries
United States
Outcome results
None listed